Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
affinity, antagonism, ascending, autoinjector, bioavailability, bridging, broker, Caucasian, cohort, comprehensive, corporate, dealer, decline, descent, formulation, government, half, hierarchical, high, inhibition, Japanese, noncash, notice, paper, pathway, powered, rationale, realized, recovery, soluble, statistically, translational, transmembrane, unrealized, written
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view